Salarius Pharmaceuticals ... (SLRX)
1.06
0.02 (1.92%)
At close: Mar 05, 2025, 12:54 PM
Salarius Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Cash & Equivalents | 5.9M | 12.11M | 29.21M | 11.12M | 3.74M | 9.83M | 19.19M | 22.42M | 66.69M | 33.85M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 14.13M | 38.66M | 26.96M | n/a |
| Long-Term Investments | n/a | n/a | 1.61M | n/a | n/a | n/a | n/a | n/a | 2.31M | n/a |
| Other Long-Term Assets | 66.85K | 130.5K | 1.8M | 247.11K | 308.67K | n/a | 60.6K | 138.08K | -2.19M | 1.25M |
| Receivables | n/a | 1.61M | n/a | 3.86M | n/a | 9.94K | 10.38K | 12.18K | n/a | n/a |
| Inventory | n/a | -1.61M | n/a | 0.00 | n/a | 187K | 432K | 454K | n/a | n/a |
| Other Current Assets | 619.76K | 803.37K | 949.22K | 822.05K | 1.91M | 288.68K | 777.1K | n/a | 908.57K | 370.4K |
| Total Current Assets | 6.52M | 14.52M | 30.16M | 15.8M | 4.69M | 10.32M | 34.53M | 62.47M | 94.56M | 34.22M |
| Property-Plant & Equipment | n/a | n/a | 7.88K | 22.64K | 25.02K | 74K | 331K | 556K | 382K | 85K |
| Goodwill & Intangibles | n/a | n/a | 8.87M | 8.87M | 8.87M | n/a | 66.4K | 53.92K | n/a | n/a |
| Total Long-Term Assets | 66.85K | 130.5K | 10.67M | 9.14M | 9.2M | 74K | 458K | 748K | 509K | 1.39M |
| Total Assets | 6.59M | 14.65M | 40.83M | 24.93M | 13.89M | 10.39M | 34.99M | 63.22M | 95.07M | 35.61M |
| Account Payables | 602.85K | 2.86M | 1.54M | 1.85M | 1.79M | 342.53K | 2M | 1.19M | 875.65K | 578.65K |
| Deferred Revenue | n/a | n/a | n/a | 383.14K | 541.7K | 4.01M | 72K | 88K | 24.38K | n/a |
| Short-Term Debt | 289.64K | n/a | n/a | 477.03K | 502.33K | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 406.75K | 1.41M | 567.79K | 442.35K | 478.55K | 4.67M | 3.77M | 2.59M | 1.95M | 488.51K |
| Total Current Liabilities | 1.3M | 4.27M | 2.11M | 2.77M | 3.31M | 1.11M | 5.89M | 3.9M | 2.82M | 995K |
| Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 39.21K | n/a | 40.41K | 41.1M |
| Total Long-Term Liabilities | n/a | 1.41M | 567.79K | 919.38K | 980.88K | 342.53K | 39.21K | 8.4K | 55K | 41.15M |
| Total Liabilities | 1.3M | 4.27M | 2.11M | 2.77M | 3.31M | 1.11M | 5.89M | 3.9M | 2.88M | 42.15M |
| Total Debt | 289.64K | n/a | n/a | 477.03K | 502.33K | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 393.00 | 225.00 | 4.52K | 2.38K | 451.00 | 1.81K | 1.78K | 1.68K | 1.57K | 221.00 |
| Retained Earnings | -76.35M | -63.81M | -32.2M | -19.43M | -12.08M | -132.96M | -111.08M | -76.65M | -37.15M | -8.01M |
| Comprehensive Income | n/a | n/a | 0.00 | 0.00 | 0.00 | -2.87M | -1.25K | -1.61K | -24.65K | -15.64M |
| Shareholders Equity | 5.29M | 10.38M | 38.72M | 22.16M | 10.58M | 9.28M | 29.11M | 59.32M | 92.19M | -6.54M |
| Total Investments | n/a | n/a | 1.61M | n/a | n/a | n/a | 14.13M | 38.66M | 26.97M | n/a |